An interventional study of laughter yoga-integrated virtual reality in Patiens in Early Stage of Chemotherapy, sponsored by Ataturk University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-01.
Sponsored by Ataturk University · Not applicable, Interventional, and Supportive care
After obtaining informed consent, pre-test applications will be performed on participants in the experimental and control groups following randomization, and information regarding treatment plans will be recorded. Patients in the experimental group will receive laughter yoga practice integrated with virtual reality videos during chemotherapy infusion. The practice is planned to be once a week for four weeks. High-resolution, adjustable virtual reality glasses with head and hand tracking features will be used for the virtual reality application. The videos will consist of relaxing content such as nature walks, beach and sea views, and will be prepared in three-dimensional, 360-degree viewing angles integrated with laughter yoga exercises. Personalized video content will be created according to the participants' preferences, and the viewing time will be limited to 10 minutes for each application. After the completion of the fourth course, data collection tools will be re-administered for post-testing purposes.
7,207 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.
This study's planned enrollment of 60 is below the median of 80 across 6,062 interventional studies indexed under Anxiety Disorders.
Browse Anxiety Disorders studies →Ataturk University is the lead sponsor of 460 studies on the registry; 126 are open to participants now.
Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
≥18 years of age, being in the early stage of chemotherapy, no surgical treatment plan, voluntary participation.
Exclusion Criteria:
psychiatric disorder, treatments other than chemotherapy, not in the early stage of chemotherapy vision and hearing problems, planned surgical procedure, skin/eye infections that would prevent the use of virtual reality, previous laughter yoga experience.
laughter yoga-integrated Vİrtual Reality
Behavioral: laughter yoga-integrated virtual reality
A digital-based behavioral approach for symptom control
Pittsburgh Sleep Quality Index
This self-report scale, used to assess sleep quality and sleep-related problems, consists of seven components. The scale was first developed by Buysse et al. in 1989, and studies have shown that it has sufficient internal consistency (Cronbach's alpha=0.80), test-retest reliability, and construct validity. The Turkish validity and reliability study of the scale was carried out by Ağargün et al., and it was shown that it can be used in the Turkish population.
Time frame: 4 week
State-Trait Anxiety Inventory (STAI)
Developed by Spielberger et al. and adapted into Turkish by Öner and Le Compte, this inventory assesses anxiety levels. It includes two subscales, each consisting of 20 items, measuring the individual's immediate anxiety level and general anxiety tendency separately. The scale is evaluated on a four-point Likert scale, with scores ranging from 20 to 80, indicating a higher level of anxiety.
Time frame: 4 week
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Jan 2027, 4 months later.
Of 3,841 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 4 months is below that.
Counting every sponsor, half of 3,943 studies reached it within 12 months; a quarter within 5 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.